Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

204
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
204
Relative Risk01:12

Relative Risk

551
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
551
Hazard Ratio01:12

Hazard Ratio

300
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
300
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

529
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
529
Therapeutic Index01:13

Therapeutic Index

5.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.7K
Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

799
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
799

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of personalized coaching on the use of digital health interventions for movement therapy in rheumatology: a randomized controlled trial.

Scientific reports·2026
Same author

Mapping environmental suitability for <i>P</i> <i>ythium insidiosum</i> under current and future climate conditions.

iScience·2026
Same author

The Digital Exposome: A Life Course Framework for Health in the Digital Age.

Journal of medical Internet research·2026
Same author

Telemedicine adoption in cardiology: Determinants and predictors identified using Bayesian Model Averaging and Machine Learning.

PLOS digital health·2026
Same author

Heterogeneity in diagnostic trajectories of ADNI participants.

Journal of neuroscience methods·2026
Same author

Correction: User Profiles and Engagement in a Hypertension Self-Management App: Cross-Sectional Survey.

Journal of medical Internet research·2026

Related Experiment Video

Updated: Oct 20, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Health risk assessment with multiple reference indices.

Pascal Petit1, Dominique J Bicout1

  • 1Univ. Grenoble Alpes, CNRS, Grenoble INP, VetAgro Sup, TIMC, 38000 Grenoble, France.

The Science of the Total Environment
|September 12, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces a novel method for aggregating risk estimates from multiple sources, improving consistency in risk assessment. The approach provides a more objective and comprehensive evaluation of toxicological reference values.

Keywords:
Health risk assessmentProbabilistic risk assessmentRisk aggregationcancer risk

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K

Related Experiment Videos

Last Updated: Oct 20, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K

Area of Science:

  • Environmental Health
  • Toxicology
  • Risk Assessment

Background:

  • Risk assessments are often challenged by conflicting conclusions from multiple reference indices.
  • Current practices typically rely on a single reference index, introducing potential bias.
  • This limitation hinders comprehensive analysis and consistent decision-making in risk management.

Purpose of the Study:

  • To develop a mathematically objective approach for constructing an aggregated risk estimate from multiple reference indices.
  • To ensure all available information is incorporated for a more robust risk assessment.
  • To enhance consistency and comparability across different studies.

Main Methods:

  • The Aggregated Risk Estimate based on Multiple Reference Indices (AREMRI) was developed.
  • AREMRI employs a weighted linear combination of risk distributions derived from individual reference indices.
  • Weights are determined by the degree of agreement among these distributions, exemplified using benzene inhalation cancer risk assessments from six regulatory agencies' inhalation unit risks (IURs).

Main Results:

  • The agreement between single reference index-based risk distributions varied significantly (0.7% to 92%).
  • Indices with higher agreement across multiple sources received greater weight in the AREMRI model.
  • The AREMRI consistently yielded a risk estimate that was the third highest among the evaluated single-source estimates across all cases.

Conclusions:

  • The proposed AREMRI approach enhances risk assessment by providing consistency and direct comparisons between studies.
  • It offers valuable insights into uncertainties associated with toxicological reference values.
  • This method supports more informed risk assessment and management decisions, particularly when dealing with significant uncertainty.